Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
AngioDynamics
ANGO
$655M
| $7.95M | ﹤0.01% |
1,013,776
+3,579
| +0.4% | +$24.8K |
|
3077
PUT
Patterson-UTI
PTEN
$4.34B
| $7.94M | ﹤0.01% |
735,050
+688,275
| +1,471% | +$8.37M |
|
3078
TG Therapeutics
TGTX
$7.46B
| $7.93M | ﹤0.01% |
464,462
+80,151
| +21% | +$932K |
|
3079
PUT
Golar LNG
GLNG
$5.36B
| $7.93M | ﹤0.01% |
344,900
-21,400
| -6% | -$480K |
|
3080
CALL
Danaos Corp
DAC
$2.58B
| $7.92M | ﹤0.01% |
107,000
-15,600
| -13% | -$1.06M |
|
3081
CALL
LegalZoom.com
LZ
$963M
| $7.92M | ﹤0.01% |
701,100
+212,200
| +43% | +$2.31M |
|
3082
The GEO Group
GEO
$4.11B
| $7.91M | ﹤0.01% |
730,480
+406,881
| +126% | +$3.89M |
|
3083
CALL
Silicon Laboratories
SLAB
$7.29B
| $7.91M | ﹤0.01% |
59,800
-41,500
| -41% | -$4.54M |
|
|
HIBB
3084
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $7.91M | ﹤0.01% |
109,806
-136,629
| -55% | -$7.65M |
|
3085
CALL
PTC
PTC
$16.2B
| $7.89M | ﹤0.01% |
45,100
-17,000
| -27% | -$2.61M |
|
3086
PUT
ProShares Ultra S&P500
SSO
$8.47B
| $7.88M | ﹤0.01% |
242,200
-65,600
| -21% | -$1.89M |
|
3087
Applied Optoelectronics
AAOI
$12.7B
| $7.88M | ﹤0.01% |
+407,840
| New | +$5.33M |
|
3088
Avient
AVNT
$4.25B
| $7.88M | ﹤0.01% |
189,443
-18,172
| -9% | -$634K |
|
3089
CALL
Protagonist Therapeutics
PTGX
$10B
| $7.86M | ﹤0.01% |
342,600
+11,100
| +3% | +$194K |
|
3090
Enova International
ENVA
$6.61B
| $7.85M | ﹤0.01% |
141,872
+133,738
| +1,644% | +$6.18M |
|
3091
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $7.85M | ﹤0.01% |
95,712
+37,602
| +65% | +$3.06M |
|
3092
CALL
Eastman Chemical
EMN
$8.47B
| $7.85M | ﹤0.01% |
87,400
+21,700
| +33% | +$1.73M |
|
3093
James River Group Holdings
JRVR
$193M
| $7.85M | ﹤0.01% |
849,530
+721,896
| +566% | +$8.29M |
|
3094
Flowserve
FLS
$10.3B
| $7.84M | ﹤0.01% |
190,292
-8,656
| -4% | -$333K |
|
|
ABVX
3095
Abivax
ABVX
$10.4B
| $7.84M | ﹤0.01% |
+732,867
| New | +$7.47M |
|
3096
PUT
American Eagle Outfitters
AEO
$2.71B
| $7.84M | ﹤0.01% |
370,300
-58,000
| -14% | -$1.08M |
|
3097
CALL
Global Ship Lease
GSL
$1.52B
| $7.83M | ﹤0.01% |
395,100
-47,900
| -11% | -$872K |
|
|
FNGA
3098
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $7.82M | ﹤0.01% |
33,572
-67,210
| -67% | -$12.5M |
|
3099
Veeco
VECO
$3.2B
| $7.82M | ﹤0.01% |
251,923
+105,694
| +72% | +$2.94M |
|
|
CBAY
3100
DELISTED
Cymabay Therapeutics
CBAY
| $7.8M | ﹤0.01% |
330,234
+216,927
| +191% | +$3.86M |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.